SCM06 Formula
A completed clinical study evaluating the efficacy of SCM06, a synbiotic formula in children with ASD
PROMISE Study
A flagship prospective study aimed at developing a non-invasive stool-based prediction tool for early ASD detection
China Multi-center Trial
A multi-center validation study to assess the clinical utility of microbiome-based ASD diagnostics
Why It Matters
Neurodevelopmental conditions affect millions of children worldwide, yet early detection and intervention remain limited. At MagIC, we harness microbiome science to develop non-invasive, accurate, and scalable tools that can transform how these conditions are diagnosed and managed. Autism Spectrum Disorder (ASD) is our first focus, serving as a model to explore the gut-brain connection and its clinical potential.
Our Research Platforms
Diverse Cohort
Over 2000 children recruited from clinical settings and community
Deep Metagenomic Profiling
20TB of sequencing data from over 2,500 stool samples
Preclinical & Functional Models
Gnotobiotic facilities and anaerobic chamber
Clinical Trial Infrastructure
Multi-disciplinary team of psychiatrists, pediatricians, and gastroenterologists
